BrightSpring Health Services, Inc. BTSG exceeded second-quarter expectations and raised its 2026 outlook as pharmacy and provider operations expanded together. The results strengthened the case that scale, mix and execution can lift profitability faster than revenues.The key question is whether spe…
BrightSpring Health Services, Inc. BTSG is pairing faster earnings growth with broader operating momentum, but the stock’s valuation already reflects high expectations. The company’s latest quarter showed that specialty pharmacy, infusion and home health can all contribute at once.That mix supports…
Q2 2026 saw 23% revenue growth and 44% adjusted EBITDA growth, driven by strong performance in both Pharmacy Solutions and Provider Services. Guidance for 2026 was raised, with robust cash flow, reduced leverage, and continued investment in technology and M&A.Based on BrightSpring Health Services…
Healthcare services provider BrightSpring Health Services NASDAQ:BTSGwill be reporting results this Friday morning. Here’s what you need to know.BrightSpring Health Services beat analysts’ revenue expectations last quarter, reporting revenues of $3.61 billion, up 25.6% year on year. It was an excep…
Explore more price target data and ratings for BrightSpring Health Services, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for BrightSpring Health Services, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Res…
